¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"utilization time"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
carbohydrate utilization test
ź¼öȹ° ÀÌ¿ë ½ÃÇè
drug utilization review
¾à¹° »ç¿ë °ËÅä
nitrate utilization test
Áú»ê¿° ÀÌ¿ë ½ÃÇè
acquisition time
ȹµæ ½Ã°£
activated coagulation time
Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
area under the concentration-time curve
Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
arm to lung time test
ÆÈ Æó ¼øÈ¯ ½Ã°£ ½ÃÇè
arm-to-retina circulation time
ÆÈ ¸Á¸· ¼øÈ¯ ½Ã°£
bleeding time test
ÃâÇ÷ ½Ã°£ ½ÃÇè
chair time
Áø·á ½Ã°£, Ä¡·á ½Ã°£
ȯÀÚ°¡ Áø´Ü ¹× Ä¡·á ¹Þ±â À§ÇÑ ½Ã°£.
change over time
½Ã°£¿¡ µû¸¥ º¯È
coagulation time
ÀÀ°í ½Ã°£
contact time
Á¢ÃË ½Ã°£
correlation time
»ó°ü ½Ã°£
doubling time
¹è°¡ ½Ã°£
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½